We found that 4.7% (8 out of 170) of patients with ALPS-FAS in the NIH cohort had CD4 T-cell counts below 300 cells/μL regardless of age and exact location of underlying FAS genetic defect. Here, FAS is linked to autoimmune lymphoproliferative syndrome.